Uploads
Contact
/
Login
Upload
Search Results for '2012 Guidance'
Rams Announcements !!! Weekly Bulletin
tatiana-dople
April 12, 2012
cheryl-pisano
1st Edition, August 2012
alexa-scheidler
Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A
tatiana-dople
Semi-Automated Design Guidance Enhancer (SADGE)
phoebe-click
ISO/IEC 17020:2012
alexa-scheidler
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish
lindy-dunigan
Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance
stefany-barnette
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE
trish-goza
Guidance on Flavourings
phoebe-click
Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination
test
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT
myesha-ticknor
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment
kittie-lecroy
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
pamella-moone
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements
tawny-fly
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE
conchita-marotz
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
cheryl-pisano
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New
calandra-battersby
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
briana-ranney
Why Psychometrics don’t always ‘work’ in Career Guida
pasty-toler
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits
pasty-toler
Guidance for Industry Safety Considerations for Container Labels and Carton Labeling
liane-varnes
Guidance for Industry InternetSocial Media latforms with Character Space Limitations
alida-meadow
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE
karlyn-bohler
1
2
3
4
5
6